Metraipolis › archive › dc_13ec29e33cd5

DeepVir -- Graphical Deep Matrix Factorization for "In Silico" Antiviral Repositioning: Application to COVID-19 — Europe PMC PPR:PPR271291

Source
Europe PMC
Original
https://europepmc.org/article/PPR/PPR271291
License (as archived)
CC0-1.0
Archived
2026-11-07T11:32:21.781Z
SHA-256 of the archived text
9d8832117373cc5850c4455d09db325d2450d599b6c70a26e404c709af41bb8f
Stable URL of this page
https://metraipolis.com/documento/dc_13ec29e33cd5

How to cite

DeepVir -- Graphical Deep Matrix Factorization for "In Silico" Antiviral Repositioning: Application to COVID-19 — Europe PMC PPR:PPR271291 — Europe PMC, https://europepmc.org/article/PPR/PPR271291 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_13ec29e33cd5 (Metraipolis archive dc_13ec29e33cd5, sha256 9d8832117373cc5850c4455d09db325d2450d599b6c70a26e404c709af41bb8f)
BibTeX
@misc{dc13ec29e33cd5,
  title = {DeepVir -- Graphical Deep Matrix Factorization for "In Silico" Antiviral Repositioning: Application to COVID-19 — Europe PMC PPR:PPR271291},
  howpublished = {Europe PMC},
  url = {https://europepmc.org/article/PPR/PPR271291},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_13ec29e33cd5; sha256 9d8832117373cc5850c4455d09db325d2450d599b6c70a26e404c709af41bb8f},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC, https://europepmc.org/article/PPR/PPR271291. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

This work formulates antiviral repositioning as a matrix completion problem where the antiviral drugs are along the rows and the viruses along the columns. The input matrix is partially filled, with ones in positions where the antiviral has been known to be effective against a virus. The curated metadata for antivirals (chemical structure and pathways) and viruses (genomic structure and symptoms) is encoded into our matrix completion framework as graph Laplacian regularization. We then frame the resulting multiple graph regularized matrix completion problem as deep matrix factorization. This is solved by using a novel optimization method called HyPALM (Hybrid Proximal Alternating Linearized Minimization). Results on our curated RNA drug virus association (DVA) dataset shows that the proposed approach excels over state-of-the-art graph regularized matrix completion techniques. When applied to "in silico" prediction of antivirals for COVID-19, our approach returns antivirals that are either used for treating patients or are under for trials for the same.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: arXiv, 2020 (prima pubblicazione 2020-09-22).
Identificativi: PPR PPR271291.
Pagina: https://europepmc.org/article/PPR/PPR271291. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-11-07T11:26:31.339Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.